BIOMARKERS OF BONE AND CARTILAGE REMODELING IN THE EVALUATION OF EARLY STAGES OF PRIMARY KNEE OSTEOARTHRITIS
- Authors: Belova S.V1, Gladkova E.V1, Zubavlenko R.A1, Ulyanov V.Y.1
-
Affiliations:
- Research Institute of Traumatology, Orthopedics, and Neurosurgery, V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
- Issue: Vol 33, No 10 (2022)
- Pages: 85-88
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114714
- DOI: https://doi.org/10.29296/25877305-2022-10-18
- ID: 114714
Cite item
Abstract
Objective. To determine the informative value of biological markers of bone and cartilage remodeling in patients with early-stage primary knee osteoarthritis (KOA). Subject and methods. The investigation involved 43 patients (16 men and 27 women) aged 36-50 years with early manifestations of KOA and 21 apparently healthy individuals without locomotor diseases. The markers of bone tissue metabolism were determined in all the study participants: resorptive processes were assessed by the content of C-terminal telopeptides of type I collagen and pyridinoline; the intensity of bone formation processes was estimated by the level of osteocalcin. The concentrations of cartilage oligomeric matrix protein and cartilage glycoprotein were determined as markers of cartilage destruction. Results. The significantly elevated levels of cartilage oligomeric matrix protein and cartilage glycoprotein show evidence of articular cartilage disorganization in the examinees. In addition, there were impaired bone formation (higher osteocalcin levels) and resorption (an increase in the concentrations of C-terminal telopeptides of type I collagen and pyridinoline) processes compared with those in the control group. Conclusion. The patients with early signs of KOA without obvious clinical and radiographic manifestations were observed to have impaired bone remodeling as intensified bone formation and resorption processes, which was accompanied by cartilage matrix restructuring. An indirect assessment of the stability of the collagen network that forms the extracellular framework of the supporting connective tissues displayed a significant increase in serum pyridinoline concentrations, which could be evidence of disruption of intermolecular collagen bonds. The reliably significant changes in the content of pyridinoline suggest that this marker may be used to comprehensively evaluate the health status of patients with early manifestations of KOA when developing diagnostic and therapeutic strategies.
Full Text
About the authors
S. V Belova
Research Institute of Traumatology, Orthopedics, and Neurosurgery, V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Email: sarniito_bsv@mail.ru
Biol.D
Russian Federation,E. V Gladkova
Research Institute of Traumatology, Orthopedics, and Neurosurgery, V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Email: sarniito_bsv@mail.ru
Candidate of Biological Sciences
Russian Federation,R. A Zubavlenko
Research Institute of Traumatology, Orthopedics, and Neurosurgery, V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Email: sarniito_bsv@mail.ru
Russian Federation,
V. Yu Ulyanov
Research Institute of Traumatology, Orthopedics, and Neurosurgery, V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Author for correspondence.
Email: sarniito_bsv@mail.ru
Associate Professor, MD
Russian Federation,References
- Ислейих О.И. Внутрикостное введение аутологичной обогащенной тромбоцитами плазмы в лечении гонартроза. Дисс.. канд. мед. наук. М., 2020; 146 с.
- Алексеева Л.И., Зайцева Е.М. Субхондральная кость при остеоартрозе: новые возможности терапии. РМЖ. 2004; 20: 1133.
- Hilal G., Martel-Pelletier J., Pelletier J.P. et al. Osteoblast-like cell from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum. 1998; 41 (5): 891-9. doi: 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X
- Кабалык М.А. Биомаркеры и участники ремоделирования субхондральной кости при остеоартрозе. Тихоокеанский медицинский журнал. 2017; 1: 36-41. DOI: 10.17238/ PmJ1609-1175.2017.1.37-41
- Igarashi M., Sakamoto K., Nagaoka I. Effect of glucosamine, a therapeutic agent for osteoarthritis, on osteoblastic cell differentiation.Int J Mol Med. 2011; 28 (3): 373-9. doi: 10.3892/ijmm.2011.686
- Белова Ю.С., Гладилин Г.П. Диагностическая значимость хрящевого олигомерного матриксного протеина при соединительнотканной патологии. Врач. 2017; 10: 83-5.
- Кцоева А.А. Клиническое значение хрящевого гликопротеина-39 у больных остеоартритом в сочетании с кардиоваскулярной патологией. Автореф.. канд. мед. наук. Волгоград, 2019; 24 с.
- Kraus V.B., Nevitt M., Sandell L.J. Summary of the OA biomarkers workshop 2009-biochemical biomarkers: biology, validation, and clinical studies. Osteoarthritis Cartilage. 2010; 18 (6): 742-5. doi: 10.1016/j.joca.2010.02.014
- Шишкова В.Н. Остеопороз в практике невролога: фокус на позвоночник. Фарматека. 2013; 9: 24-8.
- Gallop P.M., Blumenfeld O.O., Seifter S. Structure and metabolism of connective 801 tissue proteins. Annu Rev Biochem. 1972; 41: 617-72. doi: 10.1146/annurev. bi.41.070172.003153
- Lindert U., Kraenzlin M., Campos-Xavier A.B. et al. Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta. Orphanet J Rare Dis. 2015; 10: 104. DOI: 10.1186/ s13023-015-0315-9
- Ильина Р.Ю., Мухамеджанова Л.Р., Уракова Е.В. Изменение биохимических маркеров метаболизма костной ткани на фоне лекарственного остеопороза у психически больных. Практическая медицина. 2013; 2: 63-6.
- Krabben A., Knevel R., Huizinga T.W.J. et al. Serum pyridinoline levels and prediction of severity of joint destruction in rheumatoid arthritis. J Rheumatol. 2013; 40 (8): 1303-6. DOI: https://doi.org/10.3899/jrheum.121392
- Takahashi M., Naito K., Abe M. et al. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther. 2004; 6 (3): 208-12. doi: 10.1186/ar1166
- Li Q., Hu L., Zhao Z. et al. Serum changes in pyridinoline, type II collagen cleavage neoepitope and osteocalcin in early stage male brucellosis patients. Sci Rep. 2020; 10: 17190. doi: 10.1038/s41598-020-72565-8